Agios Pharmaceuticals, Inc.

Q3 2026 13F Holders

Symbol
AGIO
CUSIP
00847X104
Type
Equity
Class
COM
Num filings
4
Total reported value, excl. options
$111 k
Manager Report Date Value ($000) Shares Option Type